Increased renal medullary H2O2 leads to hypertension

Hypertension

Volumn 42, Issue 1, 2003, Pages 25-30

  Makino, Ayako ^b   Skelton, Meredith M ^b   Zou, Ai Ping ^b   Cowley Jr , Allen W ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b NONE

Author keywords

Antioxidants; Blood pressure; Oxidative stress; Renal disease; Sodium

Indexed keywords

ANTIHYPERTENSIVE AGENT; CATALASE; DIETHYLDITHIOCARBAMIC ACID; HYDROGEN PEROXIDE; ISOPROSTANE; TEMPOL; 8 EPI PROSTAGLANDIN F2ALPHA; 8-EPI-PROSTAGLANDIN F2ALPHA; AMINE OXIDE; ANTIOXIDANT; DRUG DERIVATIVE; ENZYME INHIBITOR; ISOPROSTANE DERIVATIVE; PROSTAGLANDIN F2 ALPHA; SCAVENGER; SUPEROXIDE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTERIAL PRESSURE; ARTICLE; CONTROLLED STUDY; DIALYSATE; ENZYME ACTIVITY; HEMODYNAMICS; HYPERTENSION; INDWELLING CATHETER; KIDNEY MEDULLA; MALE; MICRODIALYSIS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; STATISTICAL ANALYSIS; URINARY EXCRETION; ANIMAL; BLOOD PRESSURE; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; DRUG EFFECT; METABOLISM; PATHOPHYSIOLOGY; SPIN LABELING; SPRAGUE DAWLEY RAT; URINE; VASOCONSTRICTION;

ANIMALS; ANTIHYPERTENSIVE AGENTS; ANTIOXIDANTS; BLOOD PRESSURE; CATALASE; CATHETERS, INDWELLING; CYCLIC N-OXIDES; DINOPROST; DITIOCARB; ENZYME INHIBITORS; F2-ISOPROSTANES; FREE RADICAL SCAVENGERS; HYDROGEN PEROXIDE; HYPERTENSION; KIDNEY MEDULLA; MALE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; SPIN LABELS; SUPEROXIDE DISMUTASE; SUPEROXIDES; VASOCONSTRICTION;

EID: 0038480710     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000074903.96928.91     Document Type: Article

References (45)

1. Harrison DG. Cellular and molecular mechanisms of endothelial cell dysfunction. J Clin Invest. 1997;100:2153-2157.
2. Suzuki H, Swei A, Zweifach BW, Schmid-Schönbein GW. In vivo evidence for microvascular oxidative stress in spontaneously hypertensive rats. Hypertension. 1995;25:1083-1089.
3. Griendling KK, Ollerenshaw JD, Minieri CA, Alexander RW. Angiotensin II stimulates NADH and NADPH activity in cultured vascular smooth muscle cells. Circ Res. 1994;74:1141-1148.
4. Fukai T, Siegfried MR, Ushio-Fukai M, Griendling KK, Harrison DG. Modulation of extracellular superoxide dismutase expression by angiotensin II and hypertension. Circ Res. 1999;85:23-28.
5. Grunfeld S, Hamilton CA, Mesaros S, McLain SW, Dominiczak AF, Bohr DF, Malinski T. Role of superoxide in the depressed nitric oxide production by the endothelium of genetically hypertensive rats. Hypertension. 1995;26:854-857.
6. Schnackenberg CG, Welch WJ, Wilcox CS. Normalization of blood pressure and renal vascular resistance in SHR with a membrane-permeable superoxide dismutase mimetic: role of nitric oxide. Hypertension. 1998;32:59-64.
7. Swei A, Lacy F, DeLano FA, Schmid-Schönbein GW. Oxidative stress in the Dahl hypertensive rat. Hypertension. 1997;30:1628-1633.
8. Uehara Y, Kawabata Y, Shirahase H, Wada K, Hashizume Y, Morishita S, Numabe A, Iwai J. Oxygen radical scavengers and renal protection by indapamide diuretic in salt-induced hypertension of Dahl strain rats. J Cardiovasc Pharmacol. 1993;22:S42-S46.
9. Lerman LO, Nath KA, Rodriguez-Porcel M, Krier JD, Schwartz RS, Napoli C, Romero JC. Increased oxidative stress in experimental renovascular hypertension. Hypertension. 2001;37:541-546.
10. Feng MG, Dukacz SA, Kline RL. Selective effect of tempol on renal medullary hemodynamics in spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol. 2001;281:R1420-R1425.
11. Ichihara A, Hayashi M, Hirota N, Saruta T. Superoxide inhibits neuronal nitric oxide synthase influences on afferent arterioles in spontaneously hypertensive rats. Hypertension. 2001;37:630-634.
12. Welch WJ, Tojo A, Wilcox CS. Roles of NO and oxygen radicals in tubuloglomerular feedback in SHR. Am J Physiol. 2000;278:F769-F776.
13. Meng S, Roberts LJ 2nd, Cason GW, Curry TS, Manning RD Jr. Superoxide dismutase and oxidative stress in Dahl salt-sensitive and -resistant rats. Am J Physiol. 2002;283:R732-R738.
14. Zou AP, Li N, Cowley AW Jr. Production and actions of superoxide in the renal medulla. Hypertension. 2001;37:547-553.
15. Makino A, Skelton MM, Zou AP, Roman RJ, Cowley AW Jr. Increased renal medullary oxidative stress produces hypertension. Hypertension. 2002;39:667-672.
16. Mattson DL, Lu S, Nakanishi K, Papanek PE, Cowley AW Jr. Effect of chronic renal medullary nitric oxide inhibition on blood pressure. Am J Physiol. 1994;266:H1918-H1926.
17. Cowley AW Jr, Stoll M, Greene AS, Kaldunski ML, Roman RJ, Tonellato PJ, Schork NJ, Dumas P, Jacob HJ. Genetically defined risk of salt sensitivity in an intercross of Brown Norway and Dahl S rats. Physiol Genomics. 2000;2:107-115.
18. Zou AP, Cowley AW Jr. Nitric oxide in renal cortex and medulla: an in vivo microdialysis study. Hypertension. 1997;29:194-198.
19. Zou AP, Li N, Cowley AW Jr. Production and actions of superoxide in the renal medulla. Hypertension. 2001;37:547-553.
20. 2 release from activated human leukocytes using a dihydroxyphenoxazine derivative. J Immunol Methods. 1997;202:133-141.
21. Samuni A, Krishna CM, Riesz P, Finkelstein E, Russo A. A novel metal-free low molecular weight superoxide dismutase mimic. J Biol Chem. 1988;263:17921-17924.
22. - or as SOD mimics? J Biol Chem. 1996;271:26026-26031.
23. Fridovich I. Superoxide radical and superoxide dismutases. Annu Rev Biochem. 1995;64:97-112.
24. Beswick RA, Zhang H, Marable D, Catravas JD, Hill WD, Webb RC. Long-term antioxidant administration attenuates mineralocorticoid hypertension and renal inflammatory response. Hypertension. 2001;37:781-786.
25. Nishiyama A, Fukui T, Fujisawa Y, Rahman M, Tian RX, Kimura S, Abe Y. Systemic and regional hemodynamic responses to TEMPOL in angiotensin II-infused hypertensive rats. Hypertension. 2001;37:77-83.
26. Gonzalez-Flecha BG, Evelson P, Sterin-Speziale N, Boveris A. Hydrogen peroxide metabolism and oxidative stress in cortical, medullary and papillary zone of rat kidney. Biochim Biophys Acta. 1993;1157:115-161.
27. 1 and collagen gene expression. Kidney Int. 1998;53:367-381.
28. 2-induced contraction of rat aorta in the absence of endothelium. Cardiovasc Res. 2000;47:574-585.
29. Rodriguez-Martinez MA, Garcia-Cohen EC, Baena AB. Gonzalez R, Salaices M, Marin J. Contractile responses elicited by hydrogen peroxide in aorta from normotensive and hypertensive rats: endothelial modulation and mechanism involved. Br J Pharmacol. 1998;125:1329-1335.
30. Rhoades RA, Packer CS, Meiss RA. Pulmonary vascular smooth muscle contractility: effect of free radicals. Chest. 1988;93(suppl 3):94s-95s.
31. Katusic ZS, Schugel KJ, Cosentino F, Vanhoutte P. Endothelium-dependent contractions to oxygen-derived free radicals in the canine basilar artery. Am J Physiol. 1993;264:H859-H864.
32. Omar HA, Figueroa R, Omar RA, Tejani N, Wolin MS. Hydrogen peroxide and reoxygenation cause prostaglandin-mediated contraction of human placental arteries and veins. Am J Obstet Gynecol. 1992;167:201-207.
33. Cowley AW Jr. Role of the renal medulla in volume and arterial pressure regulation. Am J Physiol. 1997;273:R1-15.
34. 2 counteracts the vasodilator and natriuretic effects of renal medullary infusion of TEMPOL. FASEB J. 2002;16:A432. Abstract.
35. Ca channel activity. Am J Physiol. 1998;275: H1283-H1289.
36. Matoba T, Shimokawa H, Nakashima M, Hirakawa Y, Mukai Y, Hirano K, Kanaide H, Takeshita A. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in mice. J Clin Invest. 2000;106:1521-1530.
37. Lacy F, Kailasam MT, O'Connor DT, Schmid-Schönbein GW, Parmer RJ. Plasma hydrogen peroxide production in human essential hypertension: role of heredity, gender, and ethnicity. Hypertension. 2000;36:878-884.
38. Jiang Z, Akey JM, Shi J, Xiong M, Wang Y, Shen Y, Xu X, Chen H, Wu H, Xiao J, Lu D, Huang W, Jin L. A polymorphism in the promoter region of catalase is associated with blood pressure levels. Hum Genet. 2001;109:95-98.
39. Swei A, Lacy F, Delano FA, Parks DA, Schmid-Schonbein GW. A mechanism of oxygen free radical production in the Dahl hypertensive rat. Microcirculation. 1999;6:179-187.
40. Pedro-Botet J, Covas MI, Martin S, Rubies-Prat J. Decreased endogenous antioxidant enzymatic status in essential hypertension. J Hum Hypertens. 2000;14:343-345.
41. 2 in angiotensin II-induced vascular hypertrophy. Hypertension. 1998;32:488-495.
42. Clayton L, Hiley C, Davies S, D'Souza R, Jones P, Strange R, Aber G. Glomerular injury induced by hydrogen peroxide: modifying influence of ACE inhibitors. Free Radic Res Commun. 1992;17:271-278.
43. Packer CS, Pelaez NJ, Johnson TC. Gender dichotomy in reactivity to the vasoactive oxidant hydrogen peroxide in spontaneously hypertensive rats. J Gend Spec Med. 2002;5:17-23.
44. Walsh SW, Wang Y. Deficient glutathione peroxidase activity in preeclampsia is associated with increased placental production of thromboxane and lipid peroxides. Am J Obstet Gynecol. 1993;169:1456-1461.
45. Touyz RM, Schiffrin EL. Increased generation of superoxide by angiotensin II in smooth muscle cells from resistance arteries of hypertensive patients: role of phospholipase D-dependent NAD(P)H oxidase-sensitive pathways. J Hypertens. 2001;19:1245-1254.